Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Why NAKA Stock dropped -3.51% Today — RQD Quant Desk Flash
Nakamoto Inc. (NAKA) carries a Roarable Rating of E (Strong Sell) with 22/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is NAKA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, Nakamoto Inc. (NASDAQ: NAKA) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 22/100 at a spot price of $6.88 (-3.51% 1D, market cap $126.2M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, NAKA ranks #1004 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does NAKA compare to AIRS and LFMD in the Health Care sector?
▼
Within the Health Care sector (Medical/Nursing Services), NAKA carries a Roarable E (22/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -31.6%. By comparison, AIRS (AirSculpt Technologies Inc.) holds a D grade (48/100 RQD, P/E N/A, ROIC -7.0%, cap $120.4M) and LFMD (LifeMD Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC -26.2%, cap $111.8M). Among the 5-stock peer group, NAKA leads on earnings multiple (N/A) while AIRS leads on capital efficiency (-7.0% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for NAKA?
▼
Per NAKA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001946573), Nakamoto Inc. generated $1.8M in revenue (-33.0% YoY), -$52.2M in net income, and -$23.5M in free cash flow against $730.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
FRED Regime × Technicals: 11% of 52W Range • RSI-14 at 33.9 (NEUTRAL RANGE)
20D Institutional Volume Accumulation (±12.5% realized swing band)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
⚔️ Adversarial Opposing Case: What Could Spark a NAKA Turnaround Squeeze
While NAKA currently carries a cautious 22/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Health Care with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($8.21) and Max Pain ($7.22) forces dealer call-delta covering toward $38.64.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why NAKA Stock dropped -3.51% Today — RQD Quant Desk Flash
Nakamoto Inc. (NAKA) dropped -3.51% to $6.88, trading at 11% of its 52-week range ($3.33 – $36.8). Stretched risk/reward at current multiples (-32% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 11% of its 52-week range ($3.33 – $36.8) with RSI-14 at 33.9 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $6.88 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 52% gross margin and $0 annual free cash flow.
Oil slips more than 1% as talks continue on ending Iran war Reuters
Nine people dead in Learjet crash in south Florida, officials say Reuters
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
The market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Haley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
Israeli strikes kill eight people in Gaza - medics say Reuters
Iran, Qatari mediators hold third day of talks to end US-Iran war Reuters
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NAKA)
- ✓Walkthrough of NAKA's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
NAKA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -33.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on NAKA today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for NAKA. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NAKA)
1. Head-to-Head Health Care Peer Comparison (NAKA vs. AIRS, LFMD, ALPS, EUDA)
Industry: Medical/Nursing Services (29 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Nakamoto Inc. (NAKA) ranks #1004 by composite RQD confidence (22/100, grade E) and #631 by equity capitalization ($126.2M). Within this direct 5-issuer industry benchmark cohort, NAKA leads on earnings valuation at N/A trailing P/E, while AIRS leads on capital efficiency and profitability with -7.0% ROIC and — gross margin. ALPS currently holds the highest overall quantitative score in the immediate peer group at 57/100 (D+) compared with NAKA at 22/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| NAKA
ACTIVE
Nakamoto Inc. | E | 22/100 | — | — | -31.6% | -3.51% | $126.2M | Benchmark Subject |
| AIRS AirSculpt Technologies Inc. | D | 48/100 | — | — | -7.0% | +15.97% | $120.4M | /airs-vs-naka → |
| LFMD LifeMD Inc. | D | 46/100 | — | 85.7% | -26.2% | +4.04% | $111.8M | /lfmd-vs-naka → |
| ALPS ALPS Group Inc Ordinary Share | D+ | 57/100 | — | — | — | -0.03% | $54.1M | /alps-vs-naka → |
| EUDA EUDA Health Holdings Limited | D- | 39/100 | — | 43.9% | -35.0% | +1.31% | $46.4M | /euda-vs-naka → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001946573In its most recent audited fiscal period (FY2025, filed 2025-12-31), Nakamoto Inc. (NAKA) reported GAAP revenue of $1.8M (-33.0% vs. FY2024 revenue of $2.7M , and -51.7% cumulative change since FY2023) , GAAP net income of -$52.2M, operating cash flow of -$23.5M, and free cash flow of -$23.5M (-661.6% YoY). On the balance sheet, NAKA closed FY2025 with $730.6M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.8M | -$52.2M | -$23.5M | -$23.5M | $730.6M | — |
| FY2024 (FY) | 2024-12-31 | $2.7M | -$3.6M | -$3.1M | -$3.1M | $3.7M | — |
| FY2023 (FY) | 2023-12-31 | $3.8M | -$1.6M | -$449.5K | -$449.5K | — | — |
3. NAKA Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs NAKA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Nakamoto Inc. (NASDAQ: NAKA) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 22/100 at a spot price of $6.88 (-3.51% 1D, market cap $126.2M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, NAKA ranks #1004 in composite RQD confidence.
How does NAKA compare to AIRS and LFMD in the Health Care sector?
Within the Health Care sector (Medical/Nursing Services), NAKA carries a Roarable E (22/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -31.6%. By comparison, AIRS (AirSculpt Technologies Inc.) holds a D grade (48/100 RQD, P/E N/A, ROIC -7.0%, cap $120.4M) and LFMD (LifeMD Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC -26.2%, cap $111.8M). Among the 5-stock peer group, NAKA leads on earnings multiple (N/A) while AIRS leads on capital efficiency (-7.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for NAKA?
Per NAKA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001946573), Nakamoto Inc. generated $1.8M in revenue (-33.0% YoY), -$52.2M in net income, and -$23.5M in free cash flow against $730.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is NAKA trading relative to its 50-day, 200-day, and 52-week technical levels?
NAKA last traded at $6.88 (-3.51% on volume of 115,676 shares), positioning the stock -16.20% below its 50-day simple moving average ($8.21) and -13.78% below its 200-day simple moving average ($7.98). Across its 52-week range of $3.33 to $36.80, NAKA sits at the 10.6% percentile with a 14-day RSI of 33.9 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($6.02 to $7.74).
NAKA Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is NAKA stock moving today?
Why NAKA Stock dropped -3.51% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-32% return on capital) under elevated 10-year interest-rate pressure.